BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32788236)

  • 1. Subtype and grade-dependent spatial heterogeneity of T-cell infiltration in pediatric glioma.
    Robinson MH; Vasquez J; Kaushal A; MacDonald TJ; Velázquez Vega JE; Schniederjan M; Dhodapkar K
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX2 immunity and tissue resident memory in children and young adults with glioma.
    Vasquez JC; Huttner A; Zhang L; Marks A; Chan A; Baehring JM; Kahle KT; Dhodapkar KM
    J Neurooncol; 2017 Aug; 134(1):41-53. PubMed ID: 28620836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigens.
    Weenink B; Draaisma K; Ooi HZ; Kros JM; Sillevis Smitt PAE; Debets R; French PJ
    Sci Rep; 2019 Oct; 9(1):14643. PubMed ID: 31601888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 Expression in Pediatric Low-Grade Gliomas Is Independent of BRAF V600E Mutational Status.
    Martin AM; Bell WR; Yuan M; Harris L; Poore B; Arnold A; Engle EL; Asnaghi L; Lim M; Raabe EH; Eberhart CG
    J Neuropathol Exp Neurol; 2020 Jan; 79(1):74-85. PubMed ID: 31819973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of diffuse lower-grade glioma based on immunological profiling.
    Wu F; Wang ZL; Wang KY; Li GZ; Chai RC; Liu YQ; Jiang HY; Zhai Y; Feng YM; Zhao Z; Zhang W
    Mol Oncol; 2020 Sep; 14(9):2081-2095. PubMed ID: 32392361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absolute quantification of tumor-infiltrating immune cells in high-grade glioma identifies prognostic and radiomics values.
    Kim AR; Choi KS; Kim MS; Kim KM; Kang H; Kim S; Chowdhury T; Yu HJ; Lee CE; Lee JH; Lee ST; Won JK; Kim JW; Kim YH; Kim TM; Park SH; Choi SH; Shin EC; Park CK
    Cancer Immunol Immunother; 2021 Jul; 70(7):1995-2008. PubMed ID: 33416947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of the Tumor-Infiltrating CD8
    Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B
    Front Immunol; 2021; 12():734956. PubMed ID: 34603316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pathological Evaluation of Autophagy-Related Protein (LC3B) and Its Association with the Infiltration of Immune Cells in Glioma.
    Mohammed SM; Elesawy YF; Abd El Aziz AM; Khairy RA
    Asian Pac J Cancer Prev; 2022 May; 23(5):1777-1784. PubMed ID: 35633564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
    Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system.
    Garcia-Fabiani MB; Comba A; Kadiyala P; Haase S; Núñez FJ; Altshuler D; Lowenstein PR; Castro MG
    Methods Enzymol; 2020; 632():369-388. PubMed ID: 32000905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma.
    Xu S; Tang L; Liu Z; Luo C; Cheng Q
    Front Immunol; 2021; 12():731048. PubMed ID: 34659218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas.
    Deng X; Lin D; Zhang X; Shen X; Yang Z; Yang L; Lu X; Yu L; Zhang N; Lin J
    J Cell Physiol; 2020 Oct; 235(10):7321-7331. PubMed ID: 32162312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of anoikis-related genes to clarify the prognosis and immune mechanisms of patients with low-grade glioma.
    Wang J; Liu Y; Qian M; Xu W; Chen J; Deng Y; Luo R; Chen J; Jia W; Liu L; Tian C
    Biochem Biophys Res Commun; 2024 Jun; 711():149894. PubMed ID: 38603834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.
    Zhang C; Li J; Wang H; Song SW
    Oncotarget; 2016 Nov; 7(45):73971-73983. PubMed ID: 27738332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of immune phenotype with IDH mutation in diffuse glioma.
    Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
    Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
    Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
    Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.